Site Search
Company Search
Get Quote
The SeriousTraders Newsletter If you are Serious about Trading, become a SeriousTrader!™
SeriousTradersSpotlight Company
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP)
Investment Considerations Tonix Pharmaceuticals is poised to capitalize on the growing demand for fibromyalgia treatments with its lead candidate, TNX-102 SL, which has demonstrated strong Phase 3 clinical results and received FDA Fast Track designation. The company’s diversified pipeline, targeting CNS disorders, autoimmune diseases, and cocaine intoxication, offers multiple avenues for growth and reduces reliance … Continue reading “Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP)”
Latest Press Releases
Filter Releases
| Symbol | Release | Time |
|---|---|---|
| {{ release.qmtopics.qmsymbol[0].symbol }} | {{ release.headline }} | {{ release.datetime | amDateFormat:'hh:mm A'}} |
SeriousTraders is part of the IBN (InvestorBrandNetwork). Other brands within the investor brand network include:
